Search hospitals > Missouri > Saint Louis
Mercy Hospital South
Claim this profileSaint Louis, Missouri 63128
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
187 reported clinical trials
7 medical researchers
Summary
Mercy Hospital South is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Cancer, Breast Cancer, Tumors, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Mercy Hospital South is involved with conducting 187 clinical trials across 345 conditions. There are 7 research doctors associated with this hospital, such as Jay W Carlson, Anish Thomas, MD, Shaun B Hanson, MD, and Jansed Agha, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Jay W CarlsonMercy Hospital Saint Louis4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
196 reported clinical trials
279 drugs studied
Anish Thomas, MDMercy Hospital1 year of reported clinical research
Studies Peripheral Arterial Disease
Studies Peripheral Vascular Disease
5 reported clinical trials
8 drugs studied
Shaun B Hanson, MDMercy Hospital South3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
1 drug studied
Jansed Agha, MDMercy Hospital South3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
1 drug studied
Clinical Trials running at Mercy Hospital South
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Bladder Cancer
Renal Cell Carcinoma
Bladder Carcinoma
Gastric Cancer
Multiple Myeloma
Squamous Cell Carcinoma
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mercy Hospital South?
Mercy Hospital South is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Cancer, Breast Cancer, Tumors, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Mercy Hospital South is involved with conducting 187 clinical trials across 345 conditions. There are 7 research doctors associated with this hospital, such as Jay W Carlson, Anish Thomas, MD, Shaun B Hanson, MD, and Jansed Agha, MD.